HNRNPA2B1 and non-small cell lung carcinoma: HNRNPA2B1 is involved in RNA-binding and pre-RNA processing and its high expression is associated with worse prognosis in NSCLC patients; overexpression of HNRNPA2B1 promotes NSCLC cell growth by activating the COX-2 signaling pathway [68].